The Board of the NSS undertook a review of currently available evidence in relation to the potential effectiveness of introducing a national, population based prostate cancer screening programme. Current evidence is insufficient to recommend a population based screening programme because of concerns that it may not improve survival or quality of life and may ultimately cause more harm than good. The Board will continue to assess new evidence as it becomes available.
The Board of the NSS undertook a thorough review of currently available evidence in relation to the potential benefits of introducing a national, population based lung cancer screening programme. Evidence is insufficient to recommend a population based lung cancer screening programme. Results from international clinical trials currently underway will provide crucial information in the future.
The Board of the NSS undertook a thorough review of the evidence available regarding the introduction of a population based bladder cancer screening programme. The outcome showed that the potential benefit of screening would at best be small as there is substantial evidence that many of the cancers detected by screening have a low tendency to progress to invasive disease and there is limited evidence to suggest that early treatment of bladder cancer detected through screening improves long-term health outcomes.